Sponsor Pipeline

Johnson & Johnson / Janssen Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
206
Active Trials
94
Recruiting
80
Phase 3
10
Disease Areas
64
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07324200
Objective Assessment of Intraocular Lens Tilt and Decentration
Trial completed
2026-08-13 NCT07324200
Objective Assessment of Intraocular Lens Tilt and Decentration
Enrollment reduced: 80 -> 71 participants
2026-08-12 NCT05957276
Global Patient Registry of Inherited Retinal Diseases
Trial completed
2026-08-04 NCT07053345
A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant…
Trial completed
2026-08-04 NCT07053345
A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant…
date change Primary completion moved earlier: 2027-06-25 -> 2026-07-13
2026-08-04 NCT07053345
A Study of Esketamine Nasal Spray in Korean Participants With Treatment-resistant…
date change Completion moved earlier: 2027-06-25 -> 2026-07-13
2026-08-01 NCT04372108
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients…
Enrollment increased: 1056 -> 1536 participants
2026-08-01 NCT07227454
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of…
Trial sites expanded: 30 -> 35 locations
2026-08-01 NCT06425991
A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or…
date change Completion pushed: 2027-03-03 -> 2028-01-13
2026-08-01 NCT06807424
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in…
Trial sites expanded: 224 -> 233 locations
2026-08-01 NCT05327114
Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory…
date change Completion moved earlier: 2029-06-18 -> 2028-07-11
2026-08-01 NCT07258511
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3…
Trial sites expanded: 109 -> 124 locations
2026-08-01 NCT07295951
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
date change Primary completion pushed: 2026-06-14 -> 2026-09-29
2026-08-01 NCT07295951
A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia
date change Completion pushed: 2026-07-13 -> 2026-09-29
2026-08-01 NCT07309445
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle…
Trial sites expanded: 13 -> 16 locations
2026-08-01 NCT07230860
A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis
Enrollment closed, study ongoing
2026-08-01 NCT07518186
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or…
Trial sites expanded: 29 -> 88 locations
2026-08-01 NCT07220824
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World…
date change Completion pushed: 2027-09-30 -> 2028-06-30
2026-08-01 NCT07030517
A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and…
Enrollment closed, study ongoing
2026-08-01 NCT06878404
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in…
date change Primary completion moved earlier: 2026-07-24 -> 2026-05-25
Showing 20 of 64 changes detected in the last 30 days.
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-05 NCT07746687 A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe… Phase 2 Not Yet Recruiting
2026-08-05 NCT07746713 A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer Phase 1 Not Yet Recruiting
2026-08-05 NCT07746765 A Study of Continued Use of Guselkumab in Participants With Crohn's Disease and… Not Yet Recruiting
2026-07-30 NCT07735793 A Study of Radical Cystectomy in Participants With Non-Muscle Invasive Bladder Cancer… Not Yet Recruiting
2026-07-21 NCT07716098 A Study of Esketamine Nasal Spray Versus Placebo Spray in Adult Participants With… Phase 3 Recruiting
Active Trials by Phase
Phase 4
6
Phase 3
74
Phase 2/3
6
Phase 2
33
Phase 1/2
11
Phase 1
47
Not specified
29
Active Trials — top 25 of 206
NCT IDTitleConditionStatus
Phase 4
NCT05201781 A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel Multiple Myeloma Recruiting
NCT07310095 A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's… Crohn Disease Recruiting
NCT07141004 A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants… Arthritis, Psoriatic Recruiting
NCT04929210 A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active… Arthritis, Psoriatic Active, Not Recruiting
NCT07030517 A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and… Multiple Myeloma Active, Not Recruiting
NCT07654751 A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are… Psoriasis Not Yet Recruiting
Phase 3
NCT05552222 A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and… Multiple Myeloma Recruiting
NCT05923073 A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active… Crohn's Disease Recruiting
NCT06319820 A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in… Non-Muscle Invasive Bladder Neoplasms Recruiting
NCT06533098 A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of… Thrombocytopenia, Neonatal Alloimmune Recruiting
NCT06449651 A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune… Thrombocytopenia, Neonatal Alloimmune Recruiting
NCT04951622 A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis Myasthenia Gravis Recruiting
NCT07225946 A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic… Prostatic Neoplasms, Castration-Resistant Recruiting
NCT01804686 A Long-term Extension Study of PCI-32765 (Ibrutinib) Chronic Lymphocytic Leukemia Recruiting
NCT04892173 JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC Carcinoma, Squamous Cell Recruiting
NCT05912517 A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus… Hemolytic Disease of the Fetus and Newborn Recruiting
NCT06559306 Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants… Depressive Disorder, Major Recruiting
NCT06662786 A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… Colorectal Neoplasms Recruiting
NCT06663332 A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants Crohns Disease Recruiting
NCT06750094 A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… Colorectal Neoplasms Recruiting
NCT06807424 A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in… Arthritis, Psoriatic Recruiting
NCT06852222 A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… Leukemia, Myeloid, Acute Recruiting
NCT06919965 A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… Non-Muscle Invasive Bladder Neoplasms Recruiting
NCT07164443 A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant… Metastatic Castration-resistant Prostate Neoplasms Recruiting
NCT07196748 A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to… Colitis, Ulcerative Recruiting
See all 206 active Johnson & Johnson / Janssen trials with filters →
Disease Areas
Get alerts when Johnson & Johnson / Janssen's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free